PUBLISHER: KBV Research | PRODUCT CODE: 1261464
PUBLISHER: KBV Research | PRODUCT CODE: 1261464
Europe Microbial Fermentation Technology Market Size, Share & Industry Trends Analysis Report By Application, By End User, By Country and Growth Forecast, 2022 - 2028
The Europe Microbial Fermentation Technology Market would witness market growth of 5.2% CAGR during the forecast period (2022-2028).
Due to the microbial biopharmaceutical industry's explosive rise over the last few years, the microbial fermentation technology market has seen an increase in demand. The advantages of utilizing microbial organisms in production processes over mammalian cell culture, such as faster development times, higher expression levels, and lower medium costs, have greatly influenced this interest. In general, microbial fermentation technology delivers cheaper production costs, higher yields, quicker development, improved scalability, decreased fluctuation between batches, and faster yields.
The industry is also expected to rise with the demand for microbiological contract manufacturing services. Currently, more than 115 business owners are actively providing microbial fermentation services. Due to the presence of reputable companies like Lonza, AbbVie Contract Manufacturing, and others, the industry is, therefore, very fragmented. The presence of so many service providers is anticipated to fuel market expansion in the upcoming years.
The European Medicines Agency, for instance, has developed a comprehensive list of accessibility guidelines and opportunities for CDMO participation during the development stage of a medical product (EMA). The EMA gives drug researchers several opportunities for early consultation and discussion before suggesting a marketing authorization application. This is intended to offer regulatory and scientific help for developing applications and ensuring a smooth validation and assessment process. In addition, government funding and growing CVD awareness in the region are driving the market for microbial fermentation technology to expand.
The Germany market dominated the Europe Microbial Fermentation Technology Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $2,249.6 million by 2028. The UK market is anticipated to grow at a CAGR of 4.3% during (2022 - 2028). Additionally, The France market would experience a CAGR of 6% during (2022 - 2028).
Based on Application, the market is segmented into Antibiotics, Recombinant Proteins, Enzymes, Monoclonal Antibodies, Probiotics Supplements, Vaccines, Biosimilars, Small Molecules and Others. Based on End User, the market is segmented into CMOs & CDMOs, Bio-Pharmaceutical Companies, Contract Research Organizations (CROs) and Others. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Biocon Limited, BioVectra Inc. (H.I.G. Capital, LLC), Danone S.A., F. Hoffmann-La Roche Ltd., Koninklijke DSM N.V., Lonza Group AG, Novozymes A/S (Novo Holdings A/S), Corbion N.V., and Bangalore Biotech Labs Pvt. Ltd. (BiOZEEN).
Scope of the Study
Market Segments covered in the Report:
By Application
- Antibiotics
- Recombinant Proteins
- Enzymes
- Monoclonal Antibodies
- Probiotics Supplements
- Vaccines
- Biosimilars
- Small Molecules
- Others
By End User
- CMOs & CDMOs
- Bio-Pharmaceutical Companies
- Contract Research Organizations (CROs)
- Others
By Country
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
Companies Profiled
- Biocon Limited
- BioVectra Inc. (H.I.G. Capital, LLC)
- Danone S.A.
- F. Hoffmann-La Roche Ltd.
- Koninklijke DSM N.V.
- Lonza Group AG
- Novozymes A/S (Novo Holdings A/S)
- Corbion N.V.
- Bangalore Biotech Labs Pvt. Ltd. (BiOZEEN)
Unique Offerings from KBV Research
- Exhaustive coverage
- Highest number of market tables and figures
- Subscription based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology
- 1.1 Market Definition
- 1.2 Objectives
- 1.3 Market Scope
- 1.4 Segmentation
- 1.4.1 Europe Microbial Fermentation Technology Market, by Application
- 1.4.2 Europe Microbial Fermentation Technology Market, by End User
- 1.4.3 Europe Microbial Fermentation Technology Market, by Country
- 1.5 Methodology for the research
Chapter 2. Market Overview
- 2.1 Introduction
- 2.1.1 Overview
- 2.1.1.1 Market Composition & Scenario
- 2.1.1 Overview
- 2.2 Key Factors Impacting the Market
- 2.2.1 Market Drivers
- 2.2.2 Market Restraints
Chapter 3. Strategies Deployed in Microbial Fermentation Technology Market
Chapter 4. Europe Microbial Fermentation Technology Market by Application
- 4.1 Europe Antibiotics Market by Country
- 4.2 Europe Recombinant Proteins Market by Country
- 4.3 Europe Enzymes Market by Country
- 4.4 Europe Monoclonal Antibodies Market by Country
- 4.5 Europe Probiotics Supplements Market by Country
- 4.6 Europe Vaccines Market by Country
- 4.7 Europe Biosimilars Market by Country
- 4.8 Europe Small Molecules Market by Country
- 4.9 Europe Others Market by Country
Chapter 5. Europe Microbial Fermentation Technology Market by End-user
- 5.1 Europe CMOs & CDMOs Market by Country
- 5.2 Europe Bio-Pharmaceutical Companies Market by Country
- 5.3 Europe Contract Research Organizations (CROs) Market by Country
- 5.4 Europe Others Market by Country
Chapter 6. Europe Microbial Fermentation Technology Market by Country
- 6.1 Germany Microbial Fermentation Technology Market
- 6.1.1 Germany Microbial Fermentation Technology Market by Application
- 6.1.2 Germany Microbial Fermentation Technology Market by End-user
- 6.2 UK Microbial Fermentation Technology Market
- 6.2.1 UK Microbial Fermentation Technology Market by Application
- 6.2.2 UK Microbial Fermentation Technology Market by End-user
- 6.3 France Microbial Fermentation Technology Market
- 6.3.1 France Microbial Fermentation Technology Market by Application
- 6.3.2 France Microbial Fermentation Technology Market by End-user
- 6.4 Russia Microbial Fermentation Technology Market
- 6.4.1 Russia Microbial Fermentation Technology Market by Application
- 6.4.2 Russia Microbial Fermentation Technology Market by End-user
- 6.5 Spain Microbial Fermentation Technology Market
- 6.5.1 Spain Microbial Fermentation Technology Market by Application
- 6.5.2 Spain Microbial Fermentation Technology Market by End-user
- 6.6 Italy Microbial Fermentation Technology Market
- 6.6.1 Italy Microbial Fermentation Technology Market by Application
- 6.6.2 Italy Microbial Fermentation Technology Market by End-user
- 6.7 Rest of Europe Microbial Fermentation Technology Market
- 6.7.1 Rest of Europe Microbial Fermentation Technology Market by Application
- 6.7.2 Rest of Europe Microbial Fermentation Technology Market by End-user
Chapter 7. Company Profiles
- 7.1 Biocon Limited
- 7.1.1 Company Overview
- 7.1.2 Financial Analysis
- 7.1.3 Segmental and Regional Analysis
- 7.1.4 Research & Development Expenses
- 7.1.5 Recent strategies and developments:
- 7.1.5.1 Acquisition and Mergers:
- 7.2 BioVectra Inc. (H.I.G. Capital, LLC)
- 7.2.1 Company Overview
- 7.2.2 Recent strategies and developments:
- 7.2.2.1 Partnerships, Collaborations, and Agreements:
- 7.2.2.2 Product Launches and Product Expansions:
- 7.2.2.3 Geographical Expansions:
- 7.3 Danone S.A.
- 7.3.1 Company Overview
- 7.3.2 Financial Analysis
- 7.3.3 Category and Regional Analysis
- 7.3.4 Recent strategies and developments:
- 7.3.4.1 Geographical Expansions:
- 7.4 F. Hoffmann-La Roche Ltd.
- 7.4.1 Company Overview
- 7.4.2 Financial Analysis
- 7.4.3 Segmental and Regional Analysis
- 7.4.4 Research & Development Expense
- 7.5 Koninklijke DSM N.V.
- 7.5.1 Company Overview
- 7.5.2 Financial Analysis
- 7.5.3 Segmental and Regional Analysis
- 7.5.4 Research & Development Expense
- 7.5.5 Recent strategies and developments:
- 7.5.5.1 Acquisition, Joint Venture and Mergers:
- 7.6 Lonza Group AG
- 7.6.1 Company Overview
- 7.6.2 Financial Analysis
- 7.6.3 Segmental and Regional Analysis
- 7.6.4 Research & Development Expenses
- 7.7 Novozymes A/S (Novo Holdings A/S)
- 7.7.1 Company Overview
- 7.7.2 Financial Analysis
- 7.7.3 Regional Analysis
- 7.7.4 Research & Development Expense
- 7.7.5 Recent strategies and developments:
- 7.7.5.1 Product Launches and Product Expansions:
- 7.8 Corbion N.V.
- 7.8.1 Company Overview
- 7.8.2 Financial Analysis
- 7.8.3 Segmental and Regional Analysis
- 7.8.4 Research & Development Expense
- 7.9 Bangalore Biotech Labs Pvt. Ltd. (BiOZEEN)
- 7.9.1 Company Overview
LIST OF TABLES
- TABLE 1 Europe Microbial Fermentation Technology Market, 2018 - 2021, USD Million
- TABLE 2 Europe Microbial Fermentation Technology Market, 2022 - 2028, USD Million
- TABLE 3 Europe Microbial Fermentation Technology Market by Application, 2018 - 2021, USD Million
- TABLE 4 Europe Microbial Fermentation Technology Market by Application, 2022 - 2028, USD Million
- TABLE 5 Europe Antibiotics Market by Country, 2018 - 2021, USD Million
- TABLE 6 Europe Antibiotics Market by Country, 2022 - 2028, USD Million
- TABLE 7 Europe Recombinant Proteins Market by Country, 2018 - 2021, USD Million
- TABLE 8 Europe Recombinant Proteins Market by Country, 2022 - 2028, USD Million
- TABLE 9 Europe Enzymes Market by Country, 2018 - 2021, USD Million
- TABLE 10 Europe Enzymes Market by Country, 2022 - 2028, USD Million
- TABLE 11 Europe Monoclonal Antibodies Market by Country, 2018 - 2021, USD Million
- TABLE 12 Europe Monoclonal Antibodies Market by Country, 2022 - 2028, USD Million
- TABLE 13 Europe Probiotics Supplements Market by Country, 2018 - 2021, USD Million
- TABLE 14 Europe Probiotics Supplements Market by Country, 2022 - 2028, USD Million
- TABLE 15 Europe Vaccines Market by Country, 2018 - 2021, USD Million
- TABLE 16 Europe Vaccines Market by Country, 2022 - 2028, USD Million
- TABLE 17 Europe Biosimilars Market by Country, 2018 - 2021, USD Million
- TABLE 18 Europe Biosimilars Market by Country, 2022 - 2028, USD Million
- TABLE 19 Europe Small Molecules Market by Country, 2018 - 2021, USD Million
- TABLE 20 Europe Small Molecules Market by Country, 2022 - 2028, USD Million
- TABLE 21 Europe Others Market by Country, 2018 - 2021, USD Million
- TABLE 22 Europe Others Market by Country, 2022 - 2028, USD Million
- TABLE 23 Europe Microbial Fermentation Technology Market by End-user, 2018 - 2021, USD Million
- TABLE 24 Europe Microbial Fermentation Technology Market by End-user, 2022 - 2028, USD Million
- TABLE 25 Europe CMOs & CDMOs Market by Country, 2018 - 2021, USD Million
- TABLE 26 Europe CMOs & CDMOs Market by Country, 2022 - 2028, USD Million
- TABLE 27 Europe Bio-Pharmaceutical Companies Market by Country, 2018 - 2021, USD Million
- TABLE 28 Europe Bio-Pharmaceutical Companies Market by Country, 2022 - 2028, USD Million
- TABLE 29 Europe Contract Research Organizations (CROs) Market by Country, 2018 - 2021, USD Million
- TABLE 30 Europe Contract Research Organizations (CROs) Market by Country, 2022 - 2028, USD Million
- TABLE 31 Europe Others Market by Country, 2018 - 2021, USD Million
- TABLE 32 Europe Others Market by Country, 2022 - 2028, USD Million
- TABLE 33 Europe Microbial Fermentation Technology Market by Country, 2018 - 2021, USD Million
- TABLE 34 Europe Microbial Fermentation Technology Market by Country, 2022 - 2028, USD Million
- TABLE 35 Germany Microbial Fermentation Technology Market, 2018 - 2021, USD Million
- TABLE 36 Germany Microbial Fermentation Technology Market, 2022 - 2028, USD Million
- TABLE 37 Germany Microbial Fermentation Technology Market by Application, 2018 - 2021, USD Million
- TABLE 38 Germany Microbial Fermentation Technology Market by Application, 2022 - 2028, USD Million
- TABLE 39 Germany Microbial Fermentation Technology Market by End-user, 2018 - 2021, USD Million
- TABLE 40 Germany Microbial Fermentation Technology Market by End-user, 2022 - 2028, USD Million
- TABLE 41 UK Microbial Fermentation Technology Market, 2018 - 2021, USD Million
- TABLE 42 UK Microbial Fermentation Technology Market, 2022 - 2028, USD Million
- TABLE 43 UK Microbial Fermentation Technology Market by Application, 2018 - 2021, USD Million
- TABLE 44 UK Microbial Fermentation Technology Market by Application, 2022 - 2028, USD Million
- TABLE 45 UK Microbial Fermentation Technology Market by End-user, 2018 - 2021, USD Million
- TABLE 46 UK Microbial Fermentation Technology Market by End-user, 2022 - 2028, USD Million
- TABLE 47 France Microbial Fermentation Technology Market, 2018 - 2021, USD Million
- TABLE 48 France Microbial Fermentation Technology Market, 2022 - 2028, USD Million
- TABLE 49 France Microbial Fermentation Technology Market by Application, 2018 - 2021, USD Million
- TABLE 50 France Microbial Fermentation Technology Market by Application, 2022 - 2028, USD Million
- TABLE 51 France Microbial Fermentation Technology Market by End-user, 2018 - 2021, USD Million
- TABLE 52 France Microbial Fermentation Technology Market by End-user, 2022 - 2028, USD Million
- TABLE 53 Russia Microbial Fermentation Technology Market, 2018 - 2021, USD Million
- TABLE 54 Russia Microbial Fermentation Technology Market, 2022 - 2028, USD Million
- TABLE 55 Russia Microbial Fermentation Technology Market by Application, 2018 - 2021, USD Million
- TABLE 56 Russia Microbial Fermentation Technology Market by Application, 2022 - 2028, USD Million
- TABLE 57 Russia Microbial Fermentation Technology Market by End-user, 2018 - 2021, USD Million
- TABLE 58 Russia Microbial Fermentation Technology Market by End-user, 2022 - 2028, USD Million
- TABLE 59 Spain Microbial Fermentation Technology Market, 2018 - 2021, USD Million
- TABLE 60 Spain Microbial Fermentation Technology Market, 2022 - 2028, USD Million
- TABLE 61 Spain Microbial Fermentation Technology Market by Application, 2018 - 2021, USD Million
- TABLE 62 Spain Microbial Fermentation Technology Market by Application, 2022 - 2028, USD Million
- TABLE 63 Spain Microbial Fermentation Technology Market by End-user, 2018 - 2021, USD Million
- TABLE 64 Spain Microbial Fermentation Technology Market by End-user, 2022 - 2028, USD Million
- TABLE 65 Italy Microbial Fermentation Technology Market, 2018 - 2021, USD Million
- TABLE 66 Italy Microbial Fermentation Technology Market, 2022 - 2028, USD Million
- TABLE 67 Italy Microbial Fermentation Technology Market by Application, 2018 - 2021, USD Million
- TABLE 68 Italy Microbial Fermentation Technology Market by Application, 2022 - 2028, USD Million
- TABLE 69 Italy Microbial Fermentation Technology Market by End-user, 2018 - 2021, USD Million
- TABLE 70 Italy Microbial Fermentation Technology Market by End-user, 2022 - 2028, USD Million
- TABLE 71 Rest of Europe Microbial Fermentation Technology Market, 2018 - 2021, USD Million
- TABLE 72 Rest of Europe Microbial Fermentation Technology Market, 2022 - 2028, USD Million
- TABLE 73 Rest of Europe Microbial Fermentation Technology Market by Application, 2018 - 2021, USD Million
- TABLE 74 Rest of Europe Microbial Fermentation Technology Market by Application, 2022 - 2028, USD Million
- TABLE 75 Rest of Europe Microbial Fermentation Technology Market by End-user, 2018 - 2021, USD Million
- TABLE 76 Rest of Europe Microbial Fermentation Technology Market by End-user, 2022 - 2028, USD Million
- TABLE 77 Key Information - Biocon Limited
- TABLE 78 Key Information - BioVectra Inc
- TABLE 79 Key information - Danone S.A.
- TABLE 80 KEY INFORMATION - F. Hoffmann-La Roche Ltd.
- TABLE 81 Key Information - Koninklijke DSM N.V.
- TABLE 82 Key Information - Lonza Group AG
- TABLE 83 key Information - Novozymes A/S
- TABLE 84 Key Information - Corbion N.V.
- TABLE 85 Key Information - BiOZEEN
List of Figures
- FIG 1 Methodology for the research
- FIG 2 Recent strategies and developments: BioVectra Inc.
